The Anti-Stress/Relaxing Agents Ingredient Market is projected to grow from USD 1,103.2 Mn in 2025 to USD 2,502.1 Mn by 2035, at a CAGR of 8.5%. Neurosensory calming modulators will dominate with a 36.0% share, while encapsulated delivery systems will lead with a 46.0% share in 2025.